Tag: Richard Zhang
Simpson, Nishimura act on USD2.1bn Japan pharma buyout
Simpson Thacher & Bartlett and Nishimura & Asahi are advising on the USD2.1 billion acquisition of Alinamin
Simpson Thacher & Bartlett and Nishimura & Asahi are advising on the USD2.1 billion acquisition of Alinamin
Shared venture documentation gaps slow India funding rounds and shape foreign capital perceptions of ecosystem maturity
Follow us on LinkedIn